
|Videos|January 10, 2015
How Hepatitis C Therapies are Changing Patient Treatment
Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.
Advertisement
Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
2
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
3
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
4
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
5












































































































































































































